5-(2-Fluorophenyl)-1-(Pyridin-3-Ylsulfonyl)-1H-Pyrrole-3-Carbaldehyde

What Critical Process Controls Preserve Aldehyde Integrity During Large-Scale Reductive Amination for Factor Xa Inhibitor Building Blocks?

In the synthesis of oral factor Xa inhibitors structurally related to pyridylsulfonylpyrrole-substituted anticoagulants, 5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde functions as the electrophilic anchor for constructing the crucial pyrrole-3-methylamine arm. Industrial batch records from multipurpose API facilities with ISO 7 cleanrooms indicate that the aldehyde is most frequently engaged in a reductive amination with (S)-3-aminopiperidine-2,6-dione derivatives under hydrogen pressure in a Hastelloy C-22 stirred autoclave. The stoichiometric ratio is maintained at 1.00:1.12 (aldehyde:amine) with 5% Pt/C (58% w/w water wet) catalyst at a loading of 0.8 mol% relative to the aldehyde, generating an imine intermediate that undergoes in situ hydrogenation at 0.35–0.40 MPa and 313 ± 2 K. A documented process deviation during technology transfer to a 1600 L glass-lined reactor revealed that residual oxygen levels above 150 ppm in the headspace promoted aldehyde oxidation to the corresponding carboxylic acid, contaminating the isolated product at 2.4% HPLC area percent and necessitating a subsequent hot ethyl acetate trituration step that reduced overall yield from 84% to 71%. Consequently, pre-purging with argon until dissolved O₂ measures ≤0.8 mg/L is now embedded in the master batch record. Conformance to ICH Q7 Q7A for active pharmaceutical ingredient GMPs is mandatory; residual solvents are controlled per USP <467> Method IV with quantitation limits for tetrahydrofuran enforced at ≤720 ppm and methanol at ≤3000 ppm. Genotoxic impurity monitoring follows the ICH M7(R2) framework with a purge factor calculation validated on a 12 kg scale, ensuring the aldehyde-bearing intermediate is purged to <1 ppm in the final micronized API before roller compaction into a direct compression blend with mannitol and croscarmellose sodium to yield film-coated tablets at 2.5 mg and 5 mg dosage strengths.

Anti-tumor Imidazopyridine and Pyrazolopyridine Congener Scaffold Assembly via a Formyl-Directed C–H Activation Strategy

Within medicinal chemistry campaigns targeting rearrangement during transfection (RET) and tropomyosin receptor kinase (Trk) inhibition, the 3-carbaldehyde handle on 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole is exploited as a directing group for Pd(II)/Pd(IV) catalyzed C–H functionalization to install aryl or heteroaryl moieties at the pyrrole C-4 position prior to annulation. In a typical 200 L glass-lined reactor operated under a nitrogen blanket, a reaction mixture consisting of the aldehyde (1.00 eq., 35.0 kg), 4-bromo-2-methylpyridine (1.25 eq.), palladium acetate (5 mol%), 1,1′-bis(diphenylphosphino)ferrocene (6 mol%), and potassium carbonate (3.0 eq.) in dimethylacetamide (350 L) is heated to 383 K for 16 h. The process engineering challenge lies in the aldehyde’s propensity to form a Schiff base with trace dimethylamine present in DMAc; the corresponding imine by-product, typically generated at 2–4% GC area when the solvent water content exceeds 400 ppm, poisons the palladium catalyst and extends the induction period by 40–60 min, as recorded by real-time calorimetry. Pre-drying of DMAc over 4Å molecular sieves to a water content of ≤150 ppm (by Karl Fischer titration) is therefore mandatory before charging. Subsequent telescoped condensation with hydrazine monohydrate yields a pyrazolo[4,3-b]pyrrole core that, after Boc deprotection under HCl/dioxane conditions (4.0 M, 278 K), is isolated as the dihydrochloride salt with polymorphic Form II confirmed by XRPD. The registration strategy for this type of advanced intermediate in a Phase II oncology asset requires adherence to ICH Q11 principles for starting material selection, with emphasis on the carryover risk of the 2-fluorophenyl aniline precursor, a structural alert for mutagenicity per ICH M7 Class 3 guidelines; Ames test data (OECD 471) on the isolated aldehyde intermediate confirm no induction at 5000 μg/plate. Final lyophilized API for intravenous infusion is formulated in 10 mg/vial presentations requiring a particulate matter count per USP <788> of ≤6000 particles/vial at ≥10 µm.

If 5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde Is Deployed as a Linchpin in Trifluoromethyl Pyridyl Insecticide Synthesis, Which Cyanation Conditions Mitigate Aldehyde Self-Condensation?

Agrochemical process development for second-generation nicotinic acetylcholine receptor competitive modulators frequently exploits 3-substituted pyridine sulfonamide pyrrole aldehydes as intermediates for the construction of the 3-cyano or 3-tetrazole bioisostere motifs. In a dedicated multiproduct insecticide synthesis suite compliant with OECD GLP Principles as adopted by national competent authorities under Directive 2004/10/EC, the aldehyde is subjected to a one-pot cyanation-oxidation sequence with hydroxylamine hydrochloride and methanesulfonic acid in N-methyl-2-pyrrolidone at 403 K. The molar charge ratio is 1.0:1.6:3.2 (aldehyde:NH₂OH·HCl:MsOH) and the reaction is monitored by online Raman spectroscopy tracking the imine oxime intermediate band at 1640 cm⁻¹ that must reach ≤1% normalized intensity before addition of the dehydrating acid. A key process risk arises from the aldehyde’s susceptibility to base-catalyzed aldol self-condensation in the presence of residual pyridine derived from the sulfonamide precursor; even 0.15% w/w of 3-sulfonylpyridine impurity triggers dimerization, forming a high-molecular-weight red tar that adheres to reactor baffles and thermowells, requiring mechanical cleaning and resulting in a 12 h downtime per campaign. Accordingly, toluene reslurrying of the aldehyde input to a pyridine content ≤0.05% w/w (by GC-FID) is a critical-to-quality checkpoint prior to cyanation. The resultant 3-cyanopyrrole intermediate is subsequently hydrolyzed under controlled basic conditions to the corresponding tetrazole derivative using sodium azide in the presence of zinc chloride catalyst. Effluent treatment must address azide destruction through nitrous acid quenching before discharge to the biological wastewater plant, with total azide discharge limit set at 0.5 mg/L per the site’s IPPC permit. The formulated end-use products, including water-dispersible granules (WG 25%) and suspension concentrates (SC 120 g/L), are registered under the FAO/WHO Joint Meeting on Pesticide Specifications manual, with accelerated storage stability testing at 327 K for 14 days per CIPAC MT 46.3, demonstrating dispersibility ≥90% after wet sieve analysis on a 75 µm mesh.

Polymeric Hole-Transport Layer Integration: Corrosion Resistance of the Sulfonamide Bridge During Vacuum Thermal Evaporation

When 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde is co-polycondensed with 2,7-dibromo-9,9-dimethyl-9H-fluorene under Suzuki conditions to yield an alternating copolymer for hole-transporting layers (HTL) in phosphorescent organic light-emitting diode (PhOLED) stacks, the aldehyde unit is first reduced to the alcohol and subsequently mesylated to participate in dibenzofuran incorporation. The initial reduction step in methyltetrahydrofuran with sodium borohydride (1.5 eq.) at 273 K is routinely executed in a 100 L glass-lined vessel under nitrogen, and the resultant benzylic alcohol intermediate is isolated by aqueous quench and MTBE extraction. This alcohol is then converted to the 4-bromobutyl ether derivative via Williamson etherification with 1,4-dibromobutane (1.8 eq.) in the presence of powdered potassium hydroxide (3.0 eq.) in dimethyl sulfoxide, a process step that demands rigorous exclusion of moisture since water content above 0.1% leads to competitive dialkylation and formation of dimeric ether byproducts that are difficult to remove from the viscous polymer-grade monomer. The crude monomer is purified by short-path distillation at 453 K and 0.01 mbar to achieve a purity of 99.95% (by HPLC) with a halogen content <5 ppm (ion chromatography), meeting the stringent specification for sublimation-grade precursors. In a 200 mm quartz crucible inside a Kurt J. Lesker vacuum thermal evaporation chamber (base pressure 3×10⁻⁷ mbar), the monomer is deposited at a rate of 1.0 Å/s onto an ITO-patterned substrate held at 298 K. A recurrent equipment observation during production-scale evaporation involves gradual sulfonamide bond scission at temperatures exceeding 523 K, liberating SO₂ and depositing a non-conductive residue on the quartz crystal microbalance sensor that causes a 15% thickness drift over 50 deposition runs unless the crucible is cleaned with aqua regia every 10 cycles. Material qualification for PhOLED manufacturing follows IEC 62321-8 with respect to restricted phthalates and RoHS Directive 2011/65/EU (Recast) Annex II substances, with a certified cadmium content <100 ppm and total polybrominated biphenyls below 1000 ppm. The finished OLED device, sealed with a UV-curable epoxy getter under a nitrogen glovebox with <1 ppm H₂O/O₂, achieves a current efficiency of 42 cd/A and an operating lifetime LT95 exceeding 5000 h at a constant current density of 10 mA/cm², values comparable to commercially benchmarked HTL formulations derived from poly(3,4-ethylenedioxythiophene):polystyrene sulfonate.